AIKATERINI ANAGNOSTOU to Anti-Allergic Agents
This is a "connection" page, showing publications AIKATERINI ANAGNOSTOU has written about Anti-Allergic Agents.
Connection Strength
2.669
-
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2025 Jan; 155(1):62-69.e1.
Score: 0.862
-
Food allergy yardstick: Where does omalizumab fit? Ann Allergy Asthma Immunol. 2025 01; 134(1):110-121.
Score: 0.847
-
Biologics and Novel Therapeutics in Food Allergy. J Allergy Clin Immunol Pract. 2026 Apr; 14(4):762-770.
Score: 0.237
-
Treatment of Food Allergy: Immunotherapy, Omalizumab, or Both. J Allergy Clin Immunol Pract. 2025 04; 13(4):731-739.
Score: 0.217
-
The Cost-Effectiveness of Omalizumab for Treatment of Food Allergy. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2481-2489.e1.
Score: 0.209
-
The use of omalizumab in food allergy. Allergy. 2024 10; 79(10):2888-2889.
Score: 0.207
-
Updates in the Management of Peanut Allergy. Annu Rev Med. 2026 Jan; 77(1):281-295.
Score: 0.058
-
BSACI guideline for the diagnosis and management of peanut and tree nut allergy. Clin Exp Allergy. 2017 Jun; 47(6):719-739.
Score: 0.032